Combination of Deuterated Levodopa With Carbidopa and Opicapone For The Treatment of Parkinson's Disease
申请人:Teva Pharmaceuticals International GmbH
公开号:US20170165381A1
公开(公告)日:2017-06-15
The present invention relates to new combinations of treatments for abnormal dopamine deficiency disorders, and related conditions, comprising deuterated catecholamine derivatives and catechol-O-methyltransferase (COMT) inhibitors.